Diabetes Care Market Report 2026

Diabetes Care Market Overview

• Diabetes Care market size has reached to $29.09 billion in 2025 • Expected to grow to $43.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Obesity Rates Fueling The Growth Of The Market Due To Increasing Demand For Weight And Glucose Management Solutions • Market Trend: Major Companies Drive Innovation In Diabetes Care With Automated Insulin Delivery Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diabetes Care Market?

Diabetes care refers to the comprehensive management and treatment of diabetes mellitus, a chronic condition characterized by high blood sugar levels. It involves a range of medical, lifestyle, and technological interventions aimed at maintaining blood glucose within a target range and preventing complications. The main product types of diabetes care are glucose monitoring devices, insulin pumps, and others. Glucose monitoring devices are medical tools designed to measure and track blood glucose levels, primarily for individuals with diabetes. The various diabetes types include type 1 diabetes, type 2 diabetes, and others and are used by several end users such as hospitals and clinics, home care settings, ambulatory care centers, and others.

What Is The Diabetes Care Market Growth Forecast?

The diabetes care market size is expected to see strong growth in the next few years. It will grow to $43.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth of digital health solutions, expansion of connected devices, rising homecare adoption, improved insulin delivery systems, increasing patient self-management. Major trends in the forecast period include rising adoption of continuous glucose monitoring, growth of home-based diabetes care, expansion of insulin pump usage, integration of digital diabetes management tools, focus on personalized diabetes treatment.

Global Diabetes Care Market Segmentation

1) By Product Type: Glucose Monitoring Devices, Insulin Pumps 2) By Diabetes Type: Type 2 Diabetes, Type 1 Diabetes, Other Diabetes Type 3) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Care Settings, Other End Users Subsegments: 1) By Glucose Monitoring Devices: Blood Glucose Monitoring (BGM), Continuous Glucose Monitoring (CGM), Flash Glucose Monitoring (FGM) 2) By Insulin Pumps: Patch Pump, Tethered Pump, Implanted Insulin Pump

What Is The Driver Of The Diabetes Care Market?

The increasing obesity rates are expected to propel the growth of the diabetes care market going forward. Obesity rates refer to the percentage of a population with a body mass index (BMI) of 30 or higher, indicating obesity. The increasing obesity rates are due to a growing reliance on sedentary lifestyles, coupled with the widespread availability and consumption of highly processed, calorie-dense foods that are often low in nutritional value, contributing to an imbalance between calorie intake and physical activity. Diabetes care plays a crucial role in addressing rising obesity rates by promoting healthier lifestyle choices, improving glucose management, and encouraging weight control through advanced treatments such as insulin therapy and continuous glucose monitoring systems. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the increasing obesity rates are driving the growth of the diabetes care industry.

Key Players In The Global Diabetes Care Market

Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.

Global Diabetes Care Market Trends and Insights

Major companies operating in the diabetes care market are focusing on developing innovative technologies, such as automated insulin delivery (AID) systems, to improve glucose management by integrating continuous glucose monitoring (CGM) systems with insulin pumps for real-time adjustments. An Automated Insulin Delivery (AID) system is a technology that combines a Continuous Glucose Monitor (CGM) with an insulin pump to automatically adjust insulin delivery based on real-time glucose levels for improved diabetes management. For instance, in February 2024, Tandem Diabetes Care Inc., a US-based manufacturer of medical equipment for diabetes treatment, introduced the Tandem Mobi, the smallest and most robust automated insulin administration device for diabetics in the world. This innovative device offers a discreet, tubed insulin pump that is fully controllable via a smartphone app, giving users the freedom to manage their diabetes without the need for a traditional handheld controller. The Tandem Mobi is waterproof and rechargeable, and it integrates with Dexcom’s continuous glucose monitoring (CGM) system to automate insulin delivery using Tandem’s proven Control-IQ technology.

What Are Latest Mergers And Acquisitions In The Diabetes Care Market?

In January 2023, Tandem Diabetes Care Inc., a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. With this acquisition, Tandem Diabetes Care aims to accelerate the development and commercialization of innovative patch pump technology to expand its product portfolio and reach a broader patient population. AMF Medical SA is a Switzerland-based company that provides medical technologies for diabetes management, specifically focused on insulin delivery.

Regional Outlook

North America was the largest region in the diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetes Care Market?

The diabetes care market consists of revenues earned by entities by providing services such as insulin therapy and medication management, nutrition and diet planning, lifestyle modification support, and telemedicine and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes care market also consists of sales of products including dietary and nutritional products, medication delivery devices, and digital and software solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetes Care Market Report 2026?

The diabetes care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.